Value Investors Gabelli, Rogers Reaffirm Bullish Stance

Edgen Stock·Mar 19 2026, 22:36

Share to

Share to

Copy link

Key Takeaways

Influential value investors Mario Gabelli and John W. Rogers Jr. publicly confirmed their bullish outlook on value stocks during a Barron's Roundtable discussion on March 19, 2026. The declaration of confidence in undervalued equities coincided with a Gabelli-hosted symposium that showcased companies like specialty chemical firm Ashland Inc., providing a tangible example of the opportunities being assessed.

Veteran Investors Bullish: Mario Gabelli and John W. Rogers Jr. signaled continued conviction in value investing strategies.
Corporate Spotlight: On the same day, Gabelli Funds' symposium featured specialty chemical firm Ashland, which has a $2.3 billion market capitalization.
Ashland Financials: Ashland was presented with a ~$50 stock price, $1.1 billion in net debt, and a total enterprise value of $3.4 billion.

Gabelli and Rogers Endorse Value Stocks on March 19

Prominent value investors Mario Gabelli and John W. Rogers Jr. restated their bullish conviction in value-oriented equities during a Barron's Roundtable discussion on March 19, 2026. Both members of the prestigious roundtable signaled their belief in the continued potential of stocks trading below their intrinsic worth, reinforcing confidence among investors focused on fundamental analysis rather than short-term market trends.

Symposium Spotlights Ashland's $3.4B Enterprise Value

Coinciding with the public endorsement, an event hosted by Gabelli Funds provided a concrete look at the types of companies attracting attention. At the firm's Annual Specialty Chemicals Symposium, Ashland Inc. (ASH) was a featured presenter. The company was detailed for investors with a market capitalization of $2.3 billion, a stock price of approximately $50, and net debt of $1.1 billion, culminating in a $3.4 billion enterprise value. Ashland's management outlined a forward-looking strategy focused on operational efficiencies, innovation-driven growth, and targeted mergers and acquisitions, representing the kind of operational and financial profile that aligns with a value investing thesis.